ALLONK
LIVE

Serial Number

90559007

Owner

Artiva Biotherapeutics, Inc.

Attorney

Jennifer Bush

First Use Date

Apr 8, 2021

Filing Date

Mar 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ALLONK Trademark

Serial Number: 90559007 • Registration: 7056075

ALLONK is a trademark filed by Artiva Biotherapeutics, Inc. on March 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Artiva Biotherapeutics, Inc. (2 trademarks)

5505 Morehouse Drive, #100

Entity Type: 03

Trademark Details

Filing Date

March 4, 2021

Registration Date

May 16, 2023

First Use Anywhere

April 8, 2021

First Use in Commerce

February 8, 2023

Published for Opposition

May 24, 2022

Goods & Services

Cells for medical or clinical use; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of lymphoma; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of breast cancer; Therapeutic pharmaceutical for the treatment of lymphoma; Therapeutic pharmaceutical for the treatment of tumors; Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of breast cancer; Biological preparations for the treatment of lymphoma; Biological preparations for the treatment of tumors; Living cells for medical use; Pharmaceutical products for the treatment of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 16, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 16, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 12, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 11, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 22, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 22, 2023 AITU
USE AMENDMENT FILED
Mar 17, 2023 IUAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 17, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2023 REAP
TEAS STATEMENT OF USE RECEIVED
Mar 6, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 15, 2022 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Oct 2, 2022 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 23, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2022 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 31, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 31, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 4, 2021 CNRT
REMOVED FROM TEAS PLUS
Oct 4, 2021 RFTP
ASSIGNED TO EXAMINER
Sep 27, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 4, 2021 NWOS
NEW APPLICATION ENTERED
Mar 8, 2021 NWAP